What is RSS?

In a world staggering under the weight of billions of web pages and cluttered email inboxes, keeping up to date with the latest pharmaceutical and medical device information you want can be hard.

Wouldn't it be better to have the latest information delivered directly to you, rather than clicking from site to site or fighting through unwanted pages of email? Well now you can, thanks to a very clever service, RSS.

There is some discussion as to what RSS stands for, but the majority go for 'Really Simple Syndication'. Put plainly, it allows you to identify the content you like and have it delivered directly to you.

It takes the hassle out of staying up to date, by giving you the very latest information in a format you want, when you want it.

Why use it?

• It's 100% opt-in, meaning you only receive the content you want and you can easily remove any feed when you don't want it anymore
• It requires no email address and is not delivered to your inbox
• You get content exactly at the time it's added to the content feed
• Content actually gets through and cannot be blocked by various filters.
• It is virus, trojan and other dangerous content free.

How do I start using RSS feeds?

In general, the first thing you need is something called a newsreader. There are many different versions, some of which are accessed using a browser, and some of which are downloadable applications. All allow you to display and subscribe to the RSS feeds you want.

You can subscribe to the feed in various ways, including by dragging the URL of the RSS feed into your news reader or by cutting and pasting the same URL into a new feed in your news reader.

Some browsers, including Firefox, Opera and Safari, have functionality which automatically picks up RSS feeds for you. For more details on these, please check their websites.

How do I get a newsreader?

There is a range of different newsreaders available and new versions are appearing all the time.

Different newsreaders work on different operating systems, so you will need to take this into account when you make your choice.

Using FDAnews RSS feeds on your site

We reserve the right to prevent the distribution of FDAnews content. Please read our Terms and Conditions for further instructions.

FDAnews does not accept any liability for its RSS feeds. Please see the Terms and Conditions for full details

News feeds by topic:	Copy URLs to RSS Reader
Clinical Trials Advisor	http://www.fdanews.com/rss/feed?rssId=10
Clinical Trials Advisor is devoted to helping pharmaceutical manufacturers, clinical researchers, IRBs and investigators improve clinical trial operations and GCP compliance. You'll get the latest regulatory and international news, as well as practical advice for maximizing your clinical investments. No other resource provides such valuable reporting and training applicable to every area of clinical trials. From ethics to information technology, training to patient recruitment, accreditation to disclosure — if it impacts clinical trials, CTA covers it.
Devices & Diagnostics Letter	http://www.fdanews.com/rss/feed?rssId=11
This is a must-read for leaders in the device and diagnostics industries who need to stay in compliance and avoid costly design and production mistakes. Each issue provides the latest regulatory news, including Part 11 compliance, software validation rules and other pre- and post-market requirements, and tells you how to slash research time, speed your products through the approval process and pass a facility inspection.
Drug GMP Report	http://www.fdanews.com/rss/feed?rssId=12
This gives you in-depth coverage of technical quality control issues that affect your drug development and production processes. Each issue provides concise, easy-to-read explanations of key regulatory trends and advice to make FDA regulatory compliance easier. You'll be able to stay up to date on the latest inspection hot spots, developments in certification procedures, electronic data requirements and evolving trends in drug GMP enforcement.
Drug Industry Daily	http://www.fdanews.com/rss/feed?rssId=13
This daily electronic briefing delivers coverage of what's happening on Capitol Hill and at the FDA, FTC, HHS, NIH and other key agencies and decision making bodies that affect the pharmaceutical industry. Each issue gives you hard reporting on top issues, such as patent exclusivity, DTC advertising, medication errors, program funding, FDA appropriations, bioterrorism, warning letters, recalls, approvals and more. Written by FDAnews' veteran staff of reporters, you get the news as it happens with the added perspective that only seasoned reporters can provide. It's the fastest, most reliable way to make sure you're an industry expert.
Generic Line	http://www.fdanews.com/rss/feed?rssId=14
Get on the inside track of how $15 billion of branded drugs coming off patent in the next five years will affect your firm. Use Generic Line, the only newsletter devoted exclusively to the generic drug industry, to stay on top of the growing interaction among brand-name companies and generic makers, including the latest cooperative agreements, plus all the crucial business, regulatory, and legislative changes affecting your business decisions.
International Medical Device Regulatory Monitor	http://www.fdanews.com/rss/feed?rssId=15
Every month you get a comprehensive briefing on the latest regulatory developments around the world, including the U.S., Europe, Latin America, Asia, Canada, Australia and more. Plus you get actual full, official English-language texts of important, hard-to-obtain proposals, regulations, rules, directives, guidances and other documents to keep you completely up-to-date on significant developments in medical device regulatory policies worldwide. Save hours on research time and overcome barriers to application approval.
International Pharmaceutical Regulatory Monitor	http://www.fdanews.com/rss/feed?rssId=16
Stay on top of key changes in pharmaceutical regulation around the world with this monthly resource for rules and standards flowing from the FDA, the European Medicines Agency, Health Canada, Australia's TGA, the International Conference on Harmonisation and other agencies in Europe, Japan and elsewhere. In addition to a comprehensive briefing, you get actual, full official English-language texts of important, hard-to-obtain proposals, regulations, rules, directives, guidances and other documents, to help you prepare better-documented, properly formatted drug applications for fastest processing.
The Food & Drug Letter	http://www.fdanews.com/rss/feed?rssId=17
The Food & Drug Letter provides reliable, in-depth analysis of how FDA's regulations and procedures will affect your current decisions and long-term plans and gives you in-depth interpretation to tell you why FDA is making or proposing revisions. Helps you chart your course for electronic signatures, drug and device GMPs, labeling, FDA inspections and much more.
The GMP Letter	http://www.fdanews.com/rss/feed?rssId=18
Use The GMP Letter to stay on top of FDA's interpretation and enforcement of the Quality System Regulation (QSR) and know which changes your firm must make to comply. Each month, The GMP Letter provides an informed report of key regulatory developments, tips on what you can do to prepare for FDA inspections, proven ways to improve design control procedures and tips on creating more effective GMP training programs.
Washington Drug Letter	http://www.fdanews.com/rss/feed?rssId=19
Washington Drug Letter provides concise summaries of FDA regulatory changes and key legislation that affects prescription and OTC drugs. Each weekly issue brings you up to date on pre-approval and post-approval issues that directly impact your operation, such as: electronic submissions, pediatric studies, user fees and NDA submissions, drug reimportation, post-market surveillance priorities, GMPs, international harmonization and more.
FDAnews Device Daily Bulletin	http://www.fdanews.com/rss/feed?rssId=5
Each day you'll receive targeted FDA regulatory, legislative and business news briefs in the pharmaceutical and biologics industries. Plus, you'll get a snapshot of international news relevant to your business. In just a few minutes you can scan major headlines and click through to read the stories you want. Sign up today and receive your first FDAnews Drug Daily Bulletin the next business day. This subscription includes a weekly email alert, FDAnews' Pharma Solution of the Week, highlighting one problem and one solution in the pharmaceutical arena.
QMN Weekly Bulletin	http://www.fdanews.com/rss/feed?rssId=25
By reading the Quality Management Network's QMN Weekly Bulletin you can keep track of the latest from the FDA, Congress and industry experts in the world of cGMP's for pharmaceutical and medical device manufacturers. Each issue delivers crucial information on regulatory changes and inspection trends, as well as a wrap-up of the major quality management news from around the world. Sign up today and start receiving The QMN Weekly Bulletin.
FDAnews Drug Daily Bulletin	http://www.fdanews.com/rss/feed?rssId=7
Each day you'll receive targeted FDA regulatory, legislative and business news briefs in the pharmaceutical and biologics industries. Plus, you'll get a snapshot of international news relevant to your business. In just a few minutes you can scan major headlines and click through to read the stories you want. Sign up today and receive your first FDAnews Drug Daily Bulletin the next business day. This subscription includes a weekly email alert, FDAnews' Pharma Solution of the Week, highlighting one problem and one solution in the pharmaceutical arena.

Terms and Conditions:

Please read this legal agreement carefully. By downloading an FDAnews RSS feed ("FDAnews feed") from FDAnews.com, you agree to be bound by the terms and conditions governing the use of our website as a whole ( http://www.fdanews.com/privacy), in addition to the terms and conditions below specifically governing your use of FDAnews feeds.

FDAnews feeds are intended solely for private, non-commercial use by individuals. Any other uses, including without limitation the distribution, sale or commercial exploitation of FDAnews feeds, in whole or in part, are strictly prohibited. FDAnews feeds are protected by the copyright laws of the United States and other countries. All individual articles, content and other elements comprising FDAnews feeds are copyrighted works.

For permission to publicly display, reproduce or distribute FDAnews feeds, including without limitation via a website or blog, please contact Desmond Barlow at dbarlow@fdanews.com. FDAnews is under no obligation to grant any permission request.

All legal rights in FDAnews feeds, including intellectual property rights, are the property of FDAnews.com and nothing in these terms grant you any legal rights in the feeds, including without limitation the right to make derivative uses of them. You acknowledge that FDAnews.com has absolute editorial control over the FDAnews feeds and you are forbidden to edit, alter or otherwise modify their content.

FDAnews feeds are available "as is." We do not warrant that FDAnews feeds will be error-free. There may be omissions, interruptions and inaccuracies in the content made available. We do not make any representations, nor do we endorse the accuracy, completeness, timeliness or reliability of any advice, opinion, statement or other content downloaded. Although we may take reasonable steps to prevent the introduction of viruses or other destructive materials that may be downloaded from via FDAnews feeds, we do not guarantee or warrant that FDAnews feeds will be free of such destructive features. Under no circumstances is FDAnews.com liable to you for any damages or harm arising from your use of FDAnews feeds. If you use or rely on FDAnews feeds, you do so exclusively at your own risk.

FDAnews.com reserves the right to modify or cease distribution of FDAnews feeds at any time, and reserves the right to require you to cease all use of its feeds at any time for any reason, including without limitation due to your failure to adhere to these terms and conditions. You hereby agree to indemnify, hold harmless and defend FDAnews.com with respect to all damages, losses, costs and expenses, including reasonable legal fees and litigation expenses, arising out of your use of FDAnews feeds and/or the breach of these terms and conditions.

FDAnews.com reserves the right to change the terms and conditions of use governing FDAnews feeds, or this website as a whole, at any time without notice. By continuing to use FDAnews.com or FDAnews feeds, you agree to be bound by any such changes.